Rogel Cancer Center: University of Michigan
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1991-01-01
- Employees
- -
- Market Cap
- -
A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2010-09-27
- Last Posted Date
- 2017-07-05
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT01209962
- Locations
- 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- Radiation: FDG-PET
- First Posted Date
- 2010-08-27
- Last Posted Date
- 2017-06-02
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 42
- Registration Number
- NCT01190527
- Locations
- 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.
- Conditions
- Chronic Myeloid Leukemia
- First Posted Date
- 2010-08-26
- Last Posted Date
- 2015-05-15
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Registration Number
- NCT01188889
- Locations
- 🇺🇸
University of Michigan Health System, Ann Arbor, Michigan, United States
Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha
- Conditions
- Chronic Myeloid Leukemia
- Interventions
- Other: Discontinuation of therapy
- First Posted Date
- 2010-02-23
- Last Posted Date
- 2016-11-15
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT01073436
- Locations
- 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States
Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain
- First Posted Date
- 2009-12-09
- Last Posted Date
- 2013-08-08
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 35
- Registration Number
- NCT01028352
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2009-12-09
- Last Posted Date
- 2017-01-30
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 53
- Registration Number
- NCT01029054
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸Mt. Sinai Medical Center, New York, New York, United States
🇺🇸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer
- Conditions
- Bladder CancerUrothelial Cancer
- Interventions
- Drug: ABI-007 (Abraxane®)
- First Posted Date
- 2009-10-15
- Last Posted Date
- 2015-09-11
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT00995488
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients
- First Posted Date
- 2009-09-23
- Last Posted Date
- 2015-12-04
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT00982995
- Locations
- 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2009-08-28
- Last Posted Date
- 2011-03-24
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 1683
- Registration Number
- NCT00967824
Computer-Based Tailored or Standard Information for Colorectal Cancer Screening
- Conditions
- Colorectal Cancer
- First Posted Date
- 2009-08-10
- Last Posted Date
- 2012-12-21
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 345
- Registration Number
- NCT00955188
- Locations
- 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
🇺🇸Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, United States